Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

CoreLogic Sees Q4, FY11 Results To Exceed High End Of Prior Guidance

RELATED NEWS
Trade CLGX now with 

CoreLogic Inc. (CLGX: Quote) said that it expects fourth-quarter and full-year results to exceed high end of prior adjusted revenue, and adjusted earnings per share guidance.

Previously, the company had expected fiscal year 2011 adjusted earnings to be in the range of $0.75-$0.80 per share and adjusted revenues of $1.350 billion - $1.370 billion. Analysts polled by Thomson Reuters expect the company to report earnings of $0.74 per share on revenues of $1.47 billion for fiscal 2011. Analysts' estimates typically exclude special items.

Looking ahead for full-year 2012, the company expects adjusted earnings to be in the range of $0.95 - $1.05, and adjusted revenue of $1.425 billion - $1.475 billion. Analysts expect the company to report earnings of $0.87 per share on revenues of $1.44 billion for fiscal 2012.

CoreLogic expects to report its fourth quarter and full-year results after the market close on February 27, 2012.

Click here to receive FREE breaking news email alerts for CoreLogic Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved sharply higher over the course of the trading day on Tuesday, extending the recovery from the sell-off seen in recent weeks. The Nasdaq and the S&P 500 closed higher for the fourth consecutive session but remain well off their mid-September highs. Despite indications that the spread of Ebola inside the U.S. has been contained, the results of a new Gallup poll show the deadly disease had made its debut on a list of the top 10 most important problems facing the country. In another hotly contested Senate race, the results of a new Suffolk University/Boston Herald poll show incumbent Sen. Jeanne Shaheen, D-N.H., clinging to a narrow lead over Republican challenger Scott Brown.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.